i-Pharm Consulting’s Post

Unlock the power of comprehensive clinical trial solutions with DocQc. From monitoring to data management, we ensure faster drug development and better patient outcomes. 🚀🔬💊📊👩⚕️ #ClinicalTrials #DataManagement #DrugDevelopment #PatientOutcomes #ClinicalResearch #HealthTech #MedicalInnovation #DocQc #PharmaSolutions #TrialMonitoring #ResearchEfficiency #HealthcareInnovation #BioPharma #LifeSciences #ClinicalData #PatientCare #TrialSolutions #MedicalResearch #HealthcareTechnology #ClinicalExcellence #PharmaceuticalResearch #MedTech #ResearchInnovation #ClinicalOutcomes #HealthSolutions

Unlock the power of comprehensive clinical trial solutions with DocQc. From monitoring to data management, we ensure faster drug development and better patient outcomes. 🚀🔬💊📊👩⚕️ #ClinicalTrials #DataManagement #DrugDevelopment #PatientOutcomes #ClinicalResearch #HealthTech #MedicalInnovation #DocQc #PharmaSolutions #TrialMonitoring #ResearchEfficiency #HealthcareInnovation #BioPharma #LifeSciences #ClinicalData #PatientCare #TrialSolutions #MedicalResearch #HealthcareTechnology #ClinicalExcellence #PharmaceuticalResearch #MedTech #ResearchInnovation #ClinicalOutcomes #HealthSolutions

Key Trends in Post-Marketing Surveillance: Boosting Drug Safety with Real-World Data 🔍 Discover the future of drug safety! 🌍📊 Dive into the key trends shaping post-marketing surveillance and how real-world data is boosting drug safety worldwide. ✔ Real-World Evidence Integration ✔ Advanced Data Analytics ✔ Patient-Centered Approaches ✔ Regulatory Collaborations Read more- https://lnkd.in/dagmkDMW 🌐 Follow ProRelix Research: For a continuous stream of exciting developments, informative slides, and expert insights in the dynamic world of Clinical Research! 🌐 📊 #drugsafety #realworlddata #postmarketingsurveillance #healthcaredata #patientsafety #FDARegulations #drugmonitoring #healthcareanalytics #evidencebasedmedicine

How long does it typically take to write a patient medical narrative? What if I told you that you can generate patient safety narratives in batches or individually—over 400+ narratives in just seconds? “JNARRATIVES” in Clinical Trial automation can reduce your time in the Clinical Trial space by 80%. Along with substantial cost savings compared to your current models, you’ll also see significant improvements in quality and efficiency. If this sounds intriguing, let’s connect: JNarratives Live Demo Calendar : → Schedule Your Meeting Here ← https://lnkd.in/g39zCfu9 #ClinicalResearch #PharmaIndustry #MedicalResearch #HealthcareInnovation #ClinicalTrials #Biopharma #DrugDevelopment #ClinicalData #Pharmacovigilance #ClinicalStudy #ClinicalOperations #RegulatoryAffairs #MedicalWriting #ClinicalSAS #ClinicalReports #MedicalResearchWriting #HealthcareEducation #LifeSciences #ClinicalDevelopment #PharmaCareers #ClinicalResearchEducation #HealthcareTraining #MedicalScience #Biotechnology #PharmaceuticalEducation #RegulatoryCompliance #DrugSafety #MedicalAffairs #ResearchAndDevelopment #ClinicalInnovation #MedicalStatistics #DataManagement #ClinicalStudyReport

This fall, join the largest commercial gathering of PV and drug safety stakeholders at the World Drug Safety Congress Americas – coming to the Boston Convention Center October 29-30 for our biggest year yet❗️ 🗣️ Tackle the critical issues faced in #pharmacovigilance and dive into groundbreaking discussions on... 𝗔𝗜 & 𝗠𝗮𝗰𝗵𝗶𝗻𝗲 𝗟𝗲𝗮𝗿𝗻𝗶𝗻𝗴: Explore how the power of AI and machine learning is used to enhance drug safety and predict risks. 𝗦𝗮𝗳𝗲𝘁𝘆 𝗥𝗶𝘀𝗸 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁: Learn about advanced strategies for managing and mitigating safety risks. 𝗡𝗲𝘅𝘁 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗧𝗲𝗰𝗵 & 𝗗𝗮𝘁𝗮: Discover how next-gen technologies and data analytics are revolutionizing drug safety. 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗦𝗮𝗳𝗲𝘁𝘆: Prioritize patient safety with the latest best practices and protocols. 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 & 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀: Embrace digital transformation and collaborative partnerships to drive progress. 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗔𝘀𝘀𝘂𝗿𝗮𝗻𝗰𝗲 & 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲: Ensure the highest standards of quality assurance and regulatory compliance. 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗦𝗮𝗳𝗲𝘁𝘆: Delve into cutting-edge research and methodologies for ensuring vaccine safety. 𝗗𝗲𝘃𝗶𝗰𝗲 𝗦𝗮𝗳𝗲𝘁𝘆: Stay ahead with the latest insights on maintaining the safety of medical devices. ... 𝘢𝘯𝘥 𝘮𝘰𝘳𝘦! Claim your 𝟳𝟬% 𝗼𝗳𝗳 𝘁𝗶𝗰𝗸𝗲𝘁 and be a part of the future of drug safety, ensuring a healthier future for all! 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝘁𝗼𝗱𝗮𝘆 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗹𝗼𝘄𝗲𝘀𝘁 𝗽𝗿𝗶𝗰𝗲 𝗽𝗼𝘀𝘀𝗶𝗯𝗹𝗲 𝗯𝗲𝗳𝗼𝗿𝗲 𝘁𝗵𝗶𝘀 𝗱𝗲𝗮𝗹 𝗲𝘅𝗽𝗶𝗿𝗲𝘀 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄 𝗮𝘁 𝗺𝗶𝗱𝗻𝗶𝗴𝗵𝘁: https://lnkd.in/gqpN6izz Pharma & biotechs, 𝘀𝗲𝗰𝘂𝗿𝗲 𝘆𝗼𝘂𝗿 𝗙𝗥𝗘𝗘 𝗽𝗮𝘀𝘀 𝗵𝗲𝗿𝗲: https://lnkd.in/gFzSXQf9 𝘓𝘰𝘰𝘬𝘪𝘯𝘨 𝘵𝘰 𝘨𝘦𝘵 𝘪𝘯𝘷𝘰𝘭𝘷𝘦𝘥? 𝗜𝗻𝗾𝘂𝗶𝗿𝗲 𝘁𝗼 𝘀𝗽𝗲𝗮𝗸 𝗵𝗲𝗿𝗲: https://lnkd.in/enjnt2ur

Consider attending this free webinar on the role of RWE in drug development and approval

As companies embark upon developing clinical trials, it is important to consider all the options you have to optimise your approach, especially with a view to the timely achievement of the key goals of drug registration and reimbursement. The latter, often referred to as the final hurdle, was not usually considered by the R&D teams of the past. However, to optimally commercialise the innovative technologies now appearing in the marketplace, securing reimbursement is crucial, and that requires the right trial design.  As this knowledge may not be available, or well developed, ‘in house’, having an independent team of advisors such as the team at Axis Health Co. is an invaluable resource when considering trial design. With their decades of experience in this area they can help you with trial-related questions such as: Are the endpoints surrogate, or final? What sort of data will be generated? Will Bayesian/adaptive statistics help, or hinder, you? Does the control arm meet the needs for reimbursement submissions? If not, will indirect comparisons be required? Is the right data to support comparison with future reimbursement competitors being included?  If you’re thinking about clinical trial design for your new technology, Axis Health Co would love to have a conversation with you, and to partner with you to provide independent, impartial advice and insights on how to make this aspect of your strategic planning as powerful as the products and teams you have. Contact us to start the conversation: [email protected] #clinicaltrials #medicalresearch #pharmaceuticals #biotech #axishealthco #clinicalresearch

In her latest Forbes article, Eileen Faucher explains the business case for expanding diversity in clinical trials. At BTH, we have developed methodologies to gain insights into best practices in this regard. Reach out to learn how better patient representation in clinical trials can be a lever of sustained competitive advantage. [email protected] #competitiveintelligence #forbes #healthequity #clinicaltrialdiversity

In #RareDisease development, close alignment with #patients needs and expectations is indispensable and #PatientOrganizations are able to provide this connection. For a successful collaboration, it is essential for pharma to develop a good understanding of patient organizations and maintain a respectful approach. Read our latest white paper for more insights: https://bit.ly/3IiXJvy #RareDiseaseDay